Intensity Therapeutics, Inc. (INTS)
3.51
+0.13
(+3.85%)
USD |
NASDAQ |
Nov 04, 13:58
Intensity Therapeutics Price : 3.51 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 3.23 | 3.400 | 3.19 | 3.38 | 5793.00 |
| Nov 02, 2026 | 3.41 | 3.50 | 3.231 | 3.43 | 5598.00 |
| Oct 30, 2026 | 3.41 | 3.455 | 3.21 | 3.40 | 16117.00 |
| Oct 29, 2026 | 3.43 | 3.43 | 3.140 | 3.34 | 7654.00 |
| Oct 28, 2026 | 3.21 | 3.38 | 3.21 | 3.38 | 1416.00 |
| Oct 27, 2026 | 3.15 | 3.27 | 3.10 | 3.18 | 15306.00 |
| Oct 26, 2026 | 3.20 | 3.24 | 3.00 | 3.20 | 10282.00 |
| Oct 23, 2026 | 3.14 | 3.31 | 3.14 | 3.25 | 6412.00 |
| Oct 22, 2026 | 3.22 | 3.509 | 3.09 | 3.19 | 6838.00 |
| Oct 21, 2026 | 3.25 | 3.51 | 3.13 | 3.142 | 9846.00 |
| Oct 20, 2026 | 3.31 | 3.31 | 3.25 | 3.28 | 2592.00 |
| Oct 19, 2026 | 3.21 | 3.295 | 3.15 | 3.29 | 7192.00 |
| Oct 16, 2026 | 3.40 | 3.40 | 3.14 | 3.35 | 32311.00 |
| Oct 15, 2026 | 3.35 | 3.55 | 3.35 | 3.38 | 8348.00 |
| Oct 14, 2026 | 3.56 | 3.58 | 3.293 | 3.42 | 25895.00 |
| Oct 13, 2026 | 3.20 | 4.04 | 3.097 | 3.55 | 123684.0 |
| Oct 12, 2026 | 3.70 | 3.70 | 3.14 | 3.31 | 41994.00 |
| Oct 09, 2026 | 3.75 | 3.75 | 3.550 | 3.63 | 16724.00 |
| Oct 08, 2026 | 3.76 | 3.80 | 3.58 | 3.68 | 19240.00 |
| Oct 07, 2026 | 3.47 | 3.87 | 3.463 | 3.80 | 17444.00 |
| Oct 06, 2026 | 3.34 | 3.67 | 3.34 | 3.55 | 7450.00 |
| Oct 05, 2026 | 3.45 | 3.75 | 3.45 | 3.45 | 28770.00 |
| Oct 02, 2026 | 3.27 | 3.45 | 3.210 | 3.44 | 15440.00 |
| Oct 01, 2026 | 3.36 | 3.563 | 3.21 | 3.21 | 15278.00 |
| Sep 30, 2026 | 3.40 | 3.457 | 3.275 | 3.37 | 21142.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 61.77 |
| Oncolytics Biotech, Inc. | 0.4184 |
| Sangamo Therapeutics, Inc. | 0.117 |
| Sarepta Therapeutics, Inc. | 19.08 |
| Anixa Biosciences, Inc. | 3.13 |
Price Related Metrics
| Price to Book Value | 1.122 |
| Earnings Yield | -137.6% |
| Market Cap | 10.34M |